Surveillance of herpes simplex virus resistance to antivirals: A 4-year survey

2013 ◽  
Vol 100 (2) ◽  
pp. 365-372 ◽  
Author(s):  
Sonia Burrel ◽  
Catherine Aime ◽  
Laurence Hermet ◽  
Zaïna Ait-Arkoub ◽  
Henri Agut ◽  
...  
2003 ◽  
Vol 16 (1) ◽  
pp. 114-128 ◽  
Author(s):  
Teresa H. Bacon ◽  
Myron J. Levin ◽  
Jeffry J. Leary ◽  
Robert T. Sarisky ◽  
David Sutton

SUMMARY Acyclovir, penciclovir, and their prodrugs have been widely used during the past two decades for the treatment of herpesvirus infections. In spite of the distribution of over 2.3 × 106 kg of these nucleoside analogues, the prevalence of acyclovir resistance in herpes simplex virus isolates from immunocompetent hosts has remained stable at approximately 0.3%. In immuncompromised patients, in whom the risk for developing resistance is much greater, the prevalence of resistant virus has also remained stable but at a higher level, typically 4 to 7%. These observations are examined in the light of characteristics of the virus, the drugs, and host factors.


2005 ◽  
Vol 59 (3) ◽  
pp. 135-136
Author(s):  
Maja Stanojevic ◽  
Sonja Zerjav ◽  
Djordje Jevtovic ◽  
Tanja Jovanovic

2004 ◽  
Vol 42 (1) ◽  
pp. 242-249 ◽  
Author(s):  
C. Danve-Szatanek ◽  
M. Aymard ◽  
D. Thouvenot ◽  
F. Morfin ◽  
G. Agius ◽  
...  

1997 ◽  
Vol 71 (5) ◽  
pp. 3872-3878 ◽  
Author(s):  
J J Sasadeusz ◽  
F Tufaro ◽  
S Safrin ◽  
K Schubert ◽  
M M Hubinette ◽  
...  

Virologie ◽  
2020 ◽  
Vol 24 (5) ◽  
pp. 325-342
Author(s):  
Sonia Burrel ◽  
Dimitrios Topalis ◽  
David Boutolleau

Sign in / Sign up

Export Citation Format

Share Document